Pancreatic Cancer Trial, Recruiting NCT04575363 Sponsor: CHU de Reims Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT04575363
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People being treated at Reims University Hospital for a pancreatic tumour that can be surgically removed, or that may become removable after treatment, with or without pre-surgery chemotherapy
  • People aged 18 or older
  • People who have read and signed the trial's consent form

Who may not be able to join:

  • People who have had a previous cancer diagnosis, unless that cancer was a type of skin cancer called basal cell carcinoma, or early-stage cervical cancer that was treated with standard cancer treatment
  • People under the age of 18
  • People whose diagnosis is not confirmed as pancreatic ductal adenocarcinoma (the most common type of pancreatic cancer) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03 10 73 62 87

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
CHU de Reims
Registry
ClinicalTrials.gov
Start date
18 October 2021
Est. completion
18 October 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

RPSA serum concentration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov